Neurocrine Biosciences Inc. Stock Performance
as on January 1, 2026 at 2:29 am IST
Day's Low
Day's High
$140.5$142.3
0.91%
Downside
0.36%
Upside
52 Week's Low
52 Week's High
$84.23$160.1840.60%
Downside
12.97%
Upside
Neurocrine Biosciences Inc. share price movements today
- Previous Close
- $140.95
- Open
- $140.63
- Volume
- 660.5K
- Day's Low - High
- $140.5 - $142.3
- 52 Week Low - High
- $84.23 - $160.18
Neurocrine Biosciences Inc. Historical Returns
- 1 Month Return
- -6.58 %
- 3 Month Return
- + 2.88 %
- 1 Year Return
- + 3.26 %
- 3 Year Return
- + 18.01 %
- 5 Year Return
- + 47.05 %
Neurocrine Biosciences Inc. Stock Fundamentals & Key Indicators
Check Neurocrine Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.1B
EPS (TTM)
6.9153
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.65%
PE Ratio (TTM)
33.64
Industry PE ratio
17.123164556962024
PEG Ratio
0.2733
EBITDA
570.0M
Revenue (TTM)
2.7B
Profit Margin
15.95%
Return On Equity TTM
14.96%
Neurocrine Biosciences Inc. Stock Valuation
Track how Neurocrine Biosciences Inc. P/E has moved over time to understand its valuation trends.
Neurocrine Biosciences Inc. in the last 5 years
Lowest (19.60x)
June 30, 2025
Industry (17.12x)
December 31, 2025
Today (33.64x)
December 31, 2025
Highest (178.01x)
September 30, 2022
Today’s Price to Earnings Ratio: 33.64x
Neurocrine Biosciences Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurocrine Biosciences Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $14.1B | 47.05% | 33.64 | 15.95% | |
| BUY | $22.4B | NA | 18.8 | 40.65% | |
| BUY | $44.9B | NA | 22.4 | 13.81% | |
| HOLD | $14.3B | -33.08% | -21.95 | -26.13% | |
| BUY | $56.0B | -23.62% | 21.28 | 28.21% |
Stock Returns calculator for Neurocrine Biosciences Inc. Stock including INR - Dollar returns
The Neurocrine Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neurocrine Biosciences Inc. investment value today
Current value as on today
₹1,08,833
Returns
₹8,833
(+8.83%)
Returns from Neurocrine Biosciences Inc. Stock
₹3,875 (+3.88%)
Dollar Returns*
₹4,957 (+4.96%)
Analyst Recommendation on Neurocrine Biosciences Inc. Stock
Based on 34 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Neurocrine Biosciences Inc.. Average target price of $179.96
Neurocrine Biosciences Inc. Share Price Target
Get share price movements and forecasts by analysts on Neurocrine Biosciences Inc..
What analysts predicted
21.21%UPSIDE
Target Price
$179.96
Current Price
$141.79
Analyzed by
34 Analysts
Target
$179.96
Neurocrine Biosciences Inc. target price $179.96, a slight upside of 21.21% compared to current price of $141.79. According to 34 analysts rating.
Neurocrine Biosciences Inc. Stock’s Investor Sentiment and Interest
Search interest for Neurocrine Biosciences Inc. Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Neurocrine Biosciences Inc. Quarterly Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Quarterly Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. News & Key Events
Today's Timeline - 27 October
Tue, 02:37 AM
-Neurocrine launches Phase 2 study for crinecerfont in pediatric CAH patients, focusing on pharmacokinetics and safety.
Tue, 02:43 AM
-Neurocrine initiates Phase 3 study for NBI-1065845 in MDD treatment, assessing its efficacy in preventing relapse.
Insights on Neurocrine Biosciences Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 572.6M → 794.9M (in $), with an average increase of 15.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 7.9M → 209.5M (in $), with an average increase of 70.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 78.4% return, outperforming this stock by 60.4%
- NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 40.6% return, outperforming this stock by 37.3%
NEGATIVE IMPACTPrice Dip
In the last 7 days, NBIX stock has moved down by -4.1%
About Neurocrine Biosciences Inc.
| Organisation | Neurocrine Biosciences Inc. |
| Headquarters | 12780 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Mr. Kyle W. Gano Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neurocrine Biosciences Inc.
Name | Title |
|---|---|
Mr. Kyle W. Gano Ph.D. | CEO & Director |
Dr. Jude Onyia Ph.D. | Chief Scientific Officer |
Mr. Eric S. Benevich | Chief Commercial Officer |
Mr. Lewis Choi | Chief Information Officer |
Jane Sorensen | Head of Investor Relations |
Mr. Matthew C. Abernethy CPA | Chief Financial Officer |
Dr. Eiry Wyn Roberts M.D. | Strategic Advisor |
Dr. Wylie W. Vale Ph.D. | Co-Founder |
Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder of Neurocrine |
Mr. Darin M. Lippoldt Esq. | Chief Legal Officer & Corporate Secretary |
FAQs
What is Neurocrine Biosciences Inc. share price today?
Neurocrine Biosciences Inc. share price today is $141.79 as on at the close of the market. Neurocrine Biosciences Inc. share today touched a day high of $142.3 and a low of $140.5.
What is the 52 week high and 52 week low for Neurocrine Biosciences Inc. share?
Neurocrine Biosciences Inc. share touched a 52 week high of $160.18 on and a 52 week low of $84.23 on . Neurocrine Biosciences Inc. stock price today i.e. is closed at $141.79,which is 11.48% down from its 52 week high and 68.34% up from its 52 week low.
What is Neurocrine Biosciences Inc.'s market capitalisation today?
Neurocrine Biosciences Inc. market capitalisation is $0.01T as on .
How to invest in Neurocrine Biosciences Inc. Stock (NBIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurocrine Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Inc. Shares that will get you 0.0106 shares as per Neurocrine Biosciences Inc. share price of $141.79 per share as on January 1, 2026 at 2:29 am IST.
What is the minimum amount required to buy Neurocrine Biosciences Inc. Stock (NBIX) from India?
Indian investors can start investing in Neurocrine Biosciences Inc. (NBIX) shares with as little as ₹89.824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.24 in Neurocrine Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurocrine Biosciences Inc. share’s latest price of $141.79 as on January 1, 2026 at 2:29 am IST, you will get 0.0705 shares of Neurocrine Biosciences Inc.. Learn more about
fractional shares .
What are the returns that Neurocrine Biosciences Inc. has given to Indian investors in the last 5 years?
Neurocrine Biosciences Inc. stock has given 47.05% share price returns and 23.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?